Biotech Values

[Hilljack]

3M has published studies for their Taper inhaler using a generic version of Advair, "3M Taper Advair". Check out the PDF and PPT links on 3M's site that compares it to Glaxo's Advair Diskus. 3M's Taper is proven more efficient at lower cost than GSK's Advair Diskus. This deal gets better and better the more I read and research it. The pieces are all there from 3M for Adamis Pharmaceuticals to move forward with a generic version of Advair supplied by 3M. I'm sure many don't realize this from Adamis' recent press release, so you can still scoop up their stock for pennies on the dollar. I am really looking forward to Adamis' conference call to shareholders this Tuesday, where hopefully this will be made abundantly clear. Looks like a big win for both companies and consumers!

GLTA